Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
Pandey
Rajesh
R
Sharma
Sadhna
S
Khuller
G K
GK
D000818:Animals; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006168:Guinea Pigs; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008081:Liposomes / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D012293:Rifampin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D008081:Liposomes; D007538:Isoniazid; D012293:Rifampin